Wearable patch devices with high adaptability to human body surfaces have emerged as a versatile platform for next-generation healthcare applications. The physical adaptability of these systems—governed by flexibility, stretchability, and intrinsic ...
Wearable patch devices with high adaptability to human body surfaces have emerged as a versatile platform for next-generation healthcare applications. The physical adaptability of these systems—governed by flexibility, stretchability, and intrinsic self-adhesion—directly determines drug‐delivery efficiency and the duration of secure attachment. Nevertheless, achieving intimate and robust skin conformity remains challenging due to mechanical modulus mismatches among device components as well as between the device and the skin. Furthermore, sustaining reliable adhesion without auxiliary medical adhesives is crucial for practical deployment. Here, we introduce wearable patch architectures and fabrication strategies that employ functional microscale structures to enhance skin conformability and intrinsic self-adhesion for advanced drug‐delivery applications.
The first part of this study presents a transmucosal patch platform featuring root‐inspired microneedles that mechanically interlock rigid microneedle lattices with a compliant substrate. The lattice struts, once engaged with the soft substrate, generate orthogonal self‐tightening effects under applied deformation, thereby ensuring durable interfacial binding across varied mechanical loading conditions. The fabrication strategy integrates ultra‐high‐resolution 3D printing for constructing geometrically complex lattice architectures with solution‐based casting, enabling seamless integration with diverse soft substrate materials.
The second part describes a UV‐blocking drug‐delivery skin patch incorporating bioinspired microscale suction‐cup structures. By engineering a microscale suction‐cup array linked through a continuous bridge architecture, the system simultaneously supports strong adhesion and efficient drug loading. Additionally, the incorporation of an avobenzone–PDMS composite endows the patch with UV‐shielding capability, facilitating safe and routine administration of phototoxic therapeutics under daily light exposure.
Altogether, these bioinspired patch platforms demonstrate how structurally engineered interfacial mechanics can overcome long-standing limitations of soft–tissue adhesion, enabling stable and irritation-free drug administration on dynamic and compliant biological surfaces.